• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状性进行性多灶性白质脑病:一例报告并文献复习

Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature.

作者信息

Zhang Yinan, Wright Crystal, Flores Angela

机构信息

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.

出版信息

J Med Case Rep. 2018 Jul 1;12(1):187. doi: 10.1186/s13256-018-1727-7.

DOI:10.1186/s13256-018-1727-7
PMID:29960601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6026501/
Abstract

BACKGROUND

We report the development of asymptomatic progressive multifocal leukoencephalopathy in a patient with multiple sclerosis on natalizumab therapy. Progressive multifocal leukoencephalopathy often presents with debilitating neurologic symptoms. Very few cases have documented a completely asymptomatic course of the disease.

CASE PRESENTATION

A 26-year-old white woman with multiple sclerosis was treated with natalizumab. She was diagnosed as having progressive multifocal leukoencephalopathy based on characteristic magnetic resonance imaging lesions after 27 infusions of natalizumab. She had no neurologic deficits at the time of diagnosis and John Cunningham virus in cerebrospinal fluid was detected at 15 copies/ml. She was initially treated with mefloquine and mirtazapine and remained asymptomatic for 3 months. She later developed worsening magnetic resonance imaging lesions related to immune reconstitution inflammatory syndrome. At that time, she received intravenously administered immunoglobulin and high-dose intravenously administered methylprednisolone with radiologic improvement of the lesions.

CONCLUSIONS

Our case report illustrates that early detection of asymptomatic progressive multifocal leukoencephalopathy and its subsequent treatment resulted in a benign clinical course. In consideration of the additional small number of cases of asymptomatic progressive multifocal leukoencephalopathy that have been reported, we conclude that routine magnetic resonance imaging surveillance is important for patients with multiple sclerosis who are at high risk for developing natalizumab-associated progressive multifocal leukoencephalopathy.

摘要

背景

我们报告了1例接受那他珠单抗治疗的多发性硬化症患者发生无症状性进行性多灶性白质脑病的情况。进行性多灶性白质脑病通常会出现使人衰弱的神经系统症状。记录到疾病完全无症状病程的病例非常少。

病例报告

1例26岁的白人女性多发性硬化症患者接受了那他珠单抗治疗。在输注那他珠单抗27次后,基于特征性磁共振成像病变,她被诊断为进行性多灶性白质脑病。诊断时她没有神经功能缺损,脑脊液中检测到约翰·坎宁安病毒,拷贝数为每毫升15个。她最初接受了甲氟喹和米氮平治疗,并且3个月内一直无症状。她后来出现了与免疫重建炎症综合征相关的磁共振成像病变恶化。当时,她接受了静脉注射免疫球蛋白和大剂量静脉注射甲泼尼龙治疗,病变在影像学上有所改善。

结论

我们的病例报告表明,无症状性进行性多灶性白质脑病的早期检测及其后续治疗导致了良性的临床病程。考虑到已报告的无症状性进行性多灶性白质脑病的其他少数病例,我们得出结论,对于有发生那他珠单抗相关进行性多灶性白质脑病高风险的多发性硬化症患者,常规磁共振成像监测很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b9c/6026501/a0036b84b249/13256_2018_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b9c/6026501/a0036b84b249/13256_2018_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b9c/6026501/a0036b84b249/13256_2018_1727_Fig1_HTML.jpg

相似文献

1
Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature.无症状性进行性多灶性白质脑病:一例报告并文献复习
J Med Case Rep. 2018 Jul 1;12(1):187. doi: 10.1186/s13256-018-1727-7.
2
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.那他珠单抗治疗期间出现无症状性进行性多灶性白质脑病并接受治疗。
J Clin Neurosci. 2016 Mar;25:145-7. doi: 10.1016/j.jocn.2015.08.027. Epub 2015 Nov 2.
3
[Natalizumab can induce progressive multifocal leucoencephalopathy].那他珠单抗可诱发进行性多灶性白质脑病。
Ugeskr Laeger. 2014 Aug 25;176(35).
4
Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.多发性硬化症患者在使用那他珠单抗后发生进行性多灶性白质脑病,成功妊娠。
Mult Scler. 2017 Mar;23(3):483-486. doi: 10.1177/1352458516678475. Epub 2016 Nov 12.
5
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].[与那他珠单抗相关的进行性多灶性白质脑病:磁共振成像在其早期诊断中的重要性]
Rev Neurol. 2015 Feb 16;60(4):164-8.
6
Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.在停用那他珠单抗后接受芬戈莫德治疗的多发性硬化症患者中,静脉注射免疫球蛋白治疗进行性多灶性白质脑病-免疫重建炎症综合征。
J Clin Neurosci. 2015 Mar;22(3):598-600. doi: 10.1016/j.jocn.2014.08.016. Epub 2014 Dec 15.
7
Evolution of MRI appearances due to progressive multifocal leucoencephalopathy following natalizumab treatment for multiple sclerosis.Natalizumab治疗多发性硬化症后因进行性多灶性白质脑病导致的MRI表现演变
BMJ Case Rep. 2015 Apr 15;2015:bcr2015210305. doi: 10.1136/bcr-2015-210305.
8
[A case of subtentorial progressive multifocal leucoencephalopathy in a patient treated with natalizumab].[1例接受那他珠单抗治疗的患者发生幕下进行性多灶性白质脑病]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):98-106. doi: 10.17116/jnevro20191192298.
9
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.TRUST研究的设计,这是一项非干预性、多中心、为期3年的前瞻性研究,旨在调查接受那他珠单抗治疗的复发缓解型多发性硬化症患者的综合患者管理方法。
BMC Neurol. 2016 Jul 12;16:98. doi: 10.1186/s12883-016-0625-0.
10
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.预测纳武单抗相关性进行性多灶性白质脑病的严重程度和功能结局。
Mult Scler. 2017 May;23(6):830-835. doi: 10.1177/1352458516667241. Epub 2016 Sep 6.

引用本文的文献

1
Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report.COVID-19 疫苗接种后并发 COVID-19 和毛霉菌病的 B 细胞慢性淋巴细胞白血病患者的进行性多灶性白质脑病:一例报告。
BMC Neurol. 2024 May 4;24(1):151. doi: 10.1186/s12883-024-03650-y.
2
Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab.接受那他珠单抗治疗的多发性硬化症患者的焦虑与疾病控制感
J Clin Med. 2023 Dec 19;13(1):13. doi: 10.3390/jcm13010013.
3
Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review.

本文引用的文献

1
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.那他珠单抗治疗多发性硬化症的长期安全性评估。
Expert Opin Drug Saf. 2017 Aug;16(8):963-972. doi: 10.1080/14740338.2017.1346082. Epub 2017 Jul 5.
2
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML.没有证据表明血浆置换疗法对那他珠单抗相关的进行性多灶性白质脑病有有益效果。
Neurology. 2017 Mar 21;88(12):1144-1152. doi: 10.1212/WNL.0000000000003740. Epub 2017 Feb 22.
3
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
接受那他珠单抗治疗的多发性硬化症患者发生进行性多灶性白质脑病的风险:一项系统评价
Cureus. 2021 Apr 30;13(4):e14764. doi: 10.7759/cureus.14764.
4
The Use of Antimalarial Drugs against Viral Infection.抗疟药物在病毒感染治疗中的应用。
Microorganisms. 2020 Jan 8;8(1):85. doi: 10.3390/microorganisms8010085.
那他珠单抗治疗期间出现无症状性进行性多灶性白质脑病并接受治疗。
J Clin Neurosci. 2016 Mar;25:145-7. doi: 10.1016/j.jocn.2015.08.027. Epub 2015 Nov 2.
4
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.那他珠单抗相关进行性多灶性白质脑病风险的分层与监测:专家组建议
J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):117-25. doi: 10.1136/jnnp-2015-311100. Epub 2015 Oct 22.
5
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.多发性硬化症中那他珠单抗并发症的神经影像学:进行性多灶性白质脑病及其他相关病变
Mult Scler Int. 2015;2015:809252. doi: 10.1155/2015/809252. Epub 2015 Sep 21.
6
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.那他珠单抗相关的进行性多灶性白质脑病的生存及功能预后预测因素
J Neurovirol. 2015 Dec;21(6):637-44. doi: 10.1007/s13365-015-0316-4. Epub 2015 Mar 14.
7
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.在那他珠单抗治疗多发性硬化症患者中无症状 PML 的结果和生存。
Ann Clin Transl Neurol. 2014 Oct;1(10):755-64. doi: 10.1002/acn3.114. Epub 2014 Oct 9.
8
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.临床无症状的 PML 和多发性硬化症患者接受那他珠单抗治疗后的免疫重建炎症综合征延长。
Mult Scler. 2013 Aug;19(9):1226-9. doi: 10.1177/1352458513481010. Epub 2013 Mar 18.
9
Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.与那他珠单抗相关的无症状性进行性多灶性白质脑病
J Neurol. 2013 Feb;260(2):665-7. doi: 10.1007/s00415-012-6759-0. Epub 2012 Dec 5.
10
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.纳武利尤单抗相关进行性多灶性白质脑病的风险。
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.